According to Nymox Pharmaceutical's latest financial reports the company's total liabilities are $3.14 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $2.1 M | 8.11% |
2021-12-31 | $1.94 M | -11.33% |
2020-12-31 | $2.19 M | 7.69% |
2019-12-31 | $2.04 M | 90.04% |
2018-12-31 | $1.07 M | -51.84% |
2017-12-31 | $2.23 M | -17.37% |
2016-12-31 | $2.69 M | -22.12% |
2015-12-31 | $3.46 M | -38.16% |
2014-12-31 | $5.6 M | -20.23% |
2013-12-31 | $7.02 M | -23.63% |
2012-12-31 | $9.19 M | -20.51% |
2011-12-31 | $11.57 M | -29.25% |
2010-12-31 | $16.35 M | 543.31% |
2009-12-31 | $2.54 M | 102.29% |
2008-12-31 | $1.25 M | -2.92% |
2007-12-31 | $1.29 M | -39.62% |
2006-12-31 | $2.14 M | -14.46% |
2005-12-31 | $2.5 M | 22.07% |
2004-12-31 | $2.05 M | 19.11% |
2003-12-31 | $1.72 M | 17.15% |
2002-12-31 | $1.47 M | 96.89% |
2001-12-31 | $0.74 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 3,137,892.38% | ๐บ๐ธ USA |
Pfizer PFE | $137.21 B | 4,358,635.71% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $34.38 B | 1,092,244.35% | ๐บ๐ธ USA |
Eli Lilly LLY | $53.14 B | 1,688,038.50% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $7.60 B | 241,450.19% | ๐บ๐ธ USA |